tiprankstipranks
Trending News
More News >
Protara Therapeutics (TARA)
NASDAQ:TARA
US Market

Protara Therapeutics (TARA) Income Statement

Compare
686 Followers

Protara Therapeutics Income Statement

Last quarter (Q4 2024), Protara Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Protara Therapeutics's net income was $-12.77M. See Protara Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -341.00K$ -247.00K$ -1.17M$ -196.00K
Operating Expenses
$ 49.15M$ 43.61M$ 37.55M$ 47.49M$ 34.44M
Depreciation and Amortization
$ 0.00$ 341.00K$ 247.00K$ 1.17M$ 196.00K
EBITDA
$ -49.15M$ -43.27M$ -64.57M$ -46.09M$ -33.78M
Operating Income
$ -49.15M$ -43.61M$ -67.06M$ -47.49M$ -34.44M
Other Income/Expenses
$ 4.56M$ 3.19M$ 1.11M$ 237.00K$ 466.00K
Pretax Income
$ -44.60M$ -40.42M$ -65.95M$ -47.25M$ -33.98M
Net Income
$ -44.60M$ -40.42M$ -64.81M$ -47.13M$ -33.51M
Per Share Metrics
Basic EPS
$ -2.17$ -3.57$ -5.76$ -4.20$ -4.63
Diluted EPS
$ -2.17$ -3.57$ -5.76$ -4.20$ -4.63
Weighted Average Shares Outstanding
20.59M 11.33M 11.26M 11.23M 7.23M
Weighted Average Shares Outstanding (Diluted)
20.59M 11.33M 11.26M 11.23M 7.23M
Currency in USD

Protara Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis